TechTalk Blog

Monthly Archives: January 2015

GenoLogics Signs Global Agreement with Pfizer

Victoria, BC, Canada – November 10, 2008 – GenoLogics, the leader in translational research informatics solutions for life sciences, today announced that […]

Vigil Health Solutions Reports Second Quarter Results

November 10, 2008 (Victoria) – Vigil Health Solutions Inc. (“Vigil”) announces the results of operations for the quarter ending September 30, 2008. […]

GenoLogics Signs Global Agreement with Pfizer to provide Informatics Solutions to Multiple Research Centers

GenoLogics signs agreement with Pfizer

GenoLogics, the leader in translational research informatics solutions for life sciences, today announced that it has signed a three year global agreement with Pfizer to provide informatics solutions to its research labs.

Under the terms of the agreement, GenoLogics will provide an enterprise enabled lab and data management system to capture, contextualize and integrate science data in multiple locations world wide. In addition to the ability to leverage data standards across labs by virtue of a common informatics platform, GenoLogics will provide Pfizer with the tools to enable web-based collaboration, bioinformatics pipelining, auditability and reporting of cross-science data.

Zymeworks Appoints Noel Hall to Its Board of Directors

Zymeworks appoints Hall

Zymeworks Inc., a privately held computational biotechnology company, today announced the appointment of Noel Hall to its board of directors. Mr. Hall’s extensive knowledge of the biotechnology industry, along with his business-building experience, will significantly contribute to Zymeworks’ growth by guiding the development of its therapeutics pipeline.

Noel Hall is a consultant to the life sciences industry with over 25 years of experience in the biotechnology sector. He was the Co-founder, President, and Director of Aspreva Pharmaceuticals, which was acquired by the Galenica Group in January 2008. Prior to Aspreva, Mr. Hall co-founded the life sciences practice of consulting firm Hill and Knowlton and served as Head of Global Strategic Planning for the firm’s worldwide pharmaceutical consulting practice.

CANTEST welcomes new Vice President of Operations

Burnaby, British Columbia – CANTEST is pleased to announce the appointment of Dr. Curtis Braun as Vice President of Operations.       In […]

Zymeworks Appoints Noel Hall to Its Board of Directors

Zymeworks Inc., a privately held computational biotechnology company, today announced the appointment of Noel Hall to its board of directors. Mr. Hall’s […]